NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stellantis N.V. (“Stellantis” or “the Company”) (NYSE: STLA). Investors who purchased Stellantis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/STLA.
Investigation Details
On July 25, 2024, Stellantis issued a press release announcing its financial results for the first half of 2024. The Company reported a steep drop in earnings that fell below forecasts, citing weak margins and high inventory at its U.S. operations. In addition, Stellantis’s Chief Executive Officer Carlos Tavares indicated that the Company was ready to dispose of underperforming brands in its portfolio, while Chief Financial Officer Natalie Knight disclosed the need to take “decisive actions to address operational challenges” in North America, including reducing production and prices for the Company’s vehicles. On this news, Stellantis’s stock price fell sharply during intraday trading on July 25, 2024.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Stellantis securities, you can assist this investigation by visiting the firm’s site: bgandg.com/STLA. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
- authID Announces 2025 Annual Shareholder Meeting Results - June 26, 2025
- STENTiT Enrolls First Patient in Clinical Trial Evaluating a Novel Stent with Regenerative Properties to Support Limb Preservation - June 26, 2025
- WillScot Named as Presenting Sponsor of Borchetta Bourbon Music City Grand Prix in Partnership with Penske Entertainment Corp. - June 26, 2025
